Search - tctmd.com

Displaying 1 - 20 of 27

Sort: Relevancy | Date

News Industry News

Clinical Trial Demonstrates That A Bioresorbable Scaffold is Non-Inferior To A Drug-Eluting Stent In Chinese Patients With Coronary Artery Disease

October 12, 2015

News Industry News

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

October 12, 2015

News Industry News

ABSORB II: Two-Year Data From The First Randomized Comparison Between Bioresorbable Vascular Scaffolds and Everolimus-Eluting Metallic Stents Show Comparable Patient Outcomes

October 12, 2015

News Industry News

Abbott Announces Positive Results Of Its Naturally Dissolving Stent From Absorb Japan Study

September 01, 2015

News Industry News

U.S. to vie with India for top bioabsorbable stent market after FDA approval

June 25, 2015

News Industry News

Abbott Announces CE Mark for New Advancement of Absorb Stent System for People with Heart Disease

May 19, 2015

News Industry News

India Coronary Stent Market to be Tripled by 2021

May 05, 2015

News Industry News

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

September 15, 2014

News Industry News

ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

September 14, 2014

News Industry News

First Patient Enrolled in PROSPECT II Clinical Trial

June 13, 2014

News Industry News

Abbott Completes Enrollment of Absorb™ Randomized Clinical Trials in the United States, Japan and China

March 10, 2014

News Industry News

Global Bifurcation Leader Tryton Medical Announces Events at TCT 2013

October 29, 2013

News Industry News

CRF and UCR Announce Initiation of PROSPECT II Clinical Trial

October 28, 2013

News Industry News

Northwestern Medicine Researchers Investigate New Stent Technology to Treat Coronary Artery Disease

August 16, 2013

News Industry News

Abbott Initiates Randomized Clinical Trial in Japan to Evaluate the Absorb™ Bioresorbable Vascular Scaffold

June 11, 2013

News Industry News

New Data Reinforce Strong Long-Term Clinical Performance of Abbott's Absorb™ Bioresorbable Vascular Scaffold

March 11, 2013

News Industry News

Abbott Initiates Clinical Trial of Absorb™ in the United States

January 07, 2013

News Industry News

Abbott Announces International Launch of the Absorb™ Bioresorbable Vascular Scaffold

September 25, 2012

News Industry News

Abbott Reinforces Global Vascular Leadership with New Data on Innovative Technologies at ACC 2012

March 20, 2012

News Industry News

Abbott Initiates Clinical Trial To Study Drug Eluting Bioresorbable Therapy For Treatment Of Peripheral Artery Disease

December 31, 2011

Advertisement

Clinical Trial Demonstrates That A Bioresorbable Scaffold is Non-Inferior To A Drug-Eluting Stent In Chinese Patients With Coronary Artery Disease

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

ABSORB II: Two-Year Data From The First Randomized Comparison Between Bioresorbable Vascular Scaffolds and Everolimus-Eluting Metallic Stents Show Comparable Patient Outcomes

Abbott Announces Positive Results Of Its Naturally Dissolving Stent From Absorb Japan Study

U.S. to vie with India for top bioabsorbable stent market after FDA approval

Abbott Announces CE Mark for New Advancement of Absorb Stent System for People with Heart Disease

India Coronary Stent Market to be Tripled by 2021

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

First Patient Enrolled in PROSPECT II Clinical Trial

Abbott Completes Enrollment of Absorb™ Randomized Clinical Trials in the United States, Japan and China

Global Bifurcation Leader Tryton Medical Announces Events at TCT 2013

CRF and UCR Announce Initiation of PROSPECT II Clinical Trial

Northwestern Medicine Researchers Investigate New Stent Technology to Treat Coronary Artery Disease

Abbott Initiates Randomized Clinical Trial in Japan to Evaluate the Absorb™ Bioresorbable Vascular Scaffold

New Data Reinforce Strong Long-Term Clinical Performance of Abbott's Absorb™ Bioresorbable Vascular Scaffold

Abbott Initiates Clinical Trial of Absorb™ in the United States

Abbott Announces International Launch of the Absorb™ Bioresorbable Vascular Scaffold

Abbott Reinforces Global Vascular Leadership with New Data on Innovative Technologies at ACC 2012

Abbott Initiates Clinical Trial To Study Drug Eluting Bioresorbable Therapy For Treatment Of Peripheral Artery Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content